Skip to content
October 9, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Popular Tags
  • Patient Advocacy and Support
  • Treatment Innovations
  • Medical Research and Clinical Trials
  • Genomics and Precision Medicine
  • Survivorship and Post-Treatment
  • Integrative Oncology and Holistic Care
  • Chemotherapy and Targeted Therapy
  • Global Breast Cancer Awareness
  • Breast Cancer Legislation and Policy
  • Breast Cancer Surgery and Reconstruction
Breaking News
groundbreaking-oklahoma-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth-1 Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth breakthrough-in-idiopathic-pulmonary-fibrosis-treatment-taladegib-shows-significant-promise-in-landmark-phase-iib-trial Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial navigating-the-intersection-of-glp-1-medications-and-breast-cancer-what-the-science-says Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says a-global-beacon-of-hope-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness beyond-the-ribbon-bcrf-transforms-grand-central-terminal-into-a-hub-for-lifesaving-research Beyond the Ribbon: BCRF Transforms Grand Central Terminal into a Hub for Lifesaving Research

Main News

groundbreaking-oklahoma-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth-1
  • Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Basiran October 9, 2026
breakthrough-in-idiopathic-pulmonary-fibrosis-treatment-taladegib-shows-significant-promise-in-landmark-phase-iib-trial
  • Medical Research and Clinical Trials

Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial

Neng Nana October 9, 2026
navigating-the-intersection-of-glp-1-medications-and-breast-cancer-what-the-science-says
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says

Iffa Jayyana October 9, 2026
a-global-beacon-of-hope-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness
  • Patient Advocacy and Support

A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

Layla Zulfa October 9, 2026
beyond-the-ribbon-bcrf-transforms-grand-central-terminal-into-a-hub-for-lifesaving-research
  • Patient Advocacy and Support

Beyond the Ribbon: BCRF Transforms Grand Central Terminal into a Hub for Lifesaving Research

Suro Senen October 9, 2026
  • Recommended
  • Popular
  • Archive
  • Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth groundbreaking-oklahoma-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth-1
    • Medical Research and Clinical Trials

    Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

    Basiran October 9, 2026
  • Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial breakthrough-in-idiopathic-pulmonary-fibrosis-treatment-taladegib-shows-significant-promise-in-landmark-phase-iib-trial
    • Medical Research and Clinical Trials

    Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial

    Neng Nana October 9, 2026
  • Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says navigating-the-intersection-of-glp-1-medications-and-breast-cancer-what-the-science-says
    • Patient Advocacy and Support

    Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says

    Iffa Jayyana October 9, 2026
  • A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness a-global-beacon-of-hope-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness
    • Patient Advocacy and Support

    A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

    Layla Zulfa October 9, 2026
  • Unlocking Hidden Data: How AI is Revolutionizing MASLD Diagnosis and Patient Care unlocking-hidden-data-how-ai-is-revolutionizing-masld-diagnosis-and-patient-care
    • Treatment Innovations

    Unlocking Hidden Data: How AI is Revolutionizing MASLD Diagnosis and Patient Care

    Siti Muinah October 9, 2026
  • Beyond the Diagnosis: Uniting the World for the 39th National Cancer Survivors Day® beyond-the-diagnosis-uniting-the-world-for-the-39th-national-cancer-survivors-day
    • Survivorship and Post-Treatment

    Beyond the Diagnosis: Uniting the World for the 39th National Cancer Survivors Day®

    Lina Irawan May 8, 2026 0
  • Detalimogene Voraplasmid Shows Promising Efficacy and Tolerability in BCG-Unresponsive NMIBC, Offering New Hope for Patients detalimogene-voraplasmid-shows-promising-efficacy-and-tolerability-in-bcg-unresponsive-nmibc-offering-new-hope-for-patients
    • Medical Research and Clinical Trials

    Detalimogene Voraplasmid Shows Promising Efficacy and Tolerability in BCG-Unresponsive NMIBC, Offering New Hope for Patients

    Lina Irawan May 9, 2026 0
  • A Paradigm Shift in Oncology: NCCN Guidelines Embrace AI to Predict, Not Just Detect, Breast Cancer a-paradigm-shift-in-oncology-nccn-guidelines-embrace-ai-to-predict-not-just-detect-breast-cancer
    • Patient Advocacy and Support

    A Paradigm Shift in Oncology: NCCN Guidelines Embrace AI to Predict, Not Just Detect, Breast Cancer

    Lina Irawan May 9, 2026 0
  • Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth groundbreaking-oklahoma-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth-1
    • Medical Research and Clinical Trials

    Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

    Basiran October 9, 2026
  • Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial breakthrough-in-idiopathic-pulmonary-fibrosis-treatment-taladegib-shows-significant-promise-in-landmark-phase-iib-trial
    • Medical Research and Clinical Trials

    Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial

    Neng Nana October 9, 2026
  • Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says navigating-the-intersection-of-glp-1-medications-and-breast-cancer-what-the-science-says
    • Patient Advocacy and Support

    Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says

    Iffa Jayyana October 9, 2026
  • A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness a-global-beacon-of-hope-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness
    • Patient Advocacy and Support

    A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

    Layla Zulfa October 9, 2026

Featured News

groundbreaking-oklahoma-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth-1
  • Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Basiran October 9, 2026
breakthrough-in-idiopathic-pulmonary-fibrosis-treatment-taladegib-shows-significant-promise-in-landmark-phase-iib-trial
  • Medical Research and Clinical Trials

Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial

Neng Nana October 9, 2026
navigating-the-intersection-of-glp-1-medications-and-breast-cancer-what-the-science-says
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says

Iffa Jayyana October 9, 2026
a-global-beacon-of-hope-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness
  • Patient Advocacy and Support

A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

Layla Zulfa October 9, 2026

General

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth groundbreaking-oklahoma-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth-1
  • Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Basiran October 9, 2026
Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial breakthrough-in-idiopathic-pulmonary-fibrosis-treatment-taladegib-shows-significant-promise-in-landmark-phase-iib-trial
  • Medical Research and Clinical Trials

Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial

Neng Nana October 9, 2026
Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says navigating-the-intersection-of-glp-1-medications-and-breast-cancer-what-the-science-says
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says

Iffa Jayyana October 9, 2026
A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness a-global-beacon-of-hope-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness
  • Patient Advocacy and Support

A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

Layla Zulfa October 9, 2026

Opinion

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth groundbreaking-oklahoma-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth-1
  • Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Basiran October 9, 2026
Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial breakthrough-in-idiopathic-pulmonary-fibrosis-treatment-taladegib-shows-significant-promise-in-landmark-phase-iib-trial
  • Medical Research and Clinical Trials

Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial

Neng Nana October 9, 2026
Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says navigating-the-intersection-of-glp-1-medications-and-breast-cancer-what-the-science-says
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says

Iffa Jayyana October 9, 2026
A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness a-global-beacon-of-hope-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness
  • Patient Advocacy and Support

A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

Layla Zulfa October 9, 2026

More

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth groundbreaking-oklahoma-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth-1
  • Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Basiran October 9, 2026
Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial breakthrough-in-idiopathic-pulmonary-fibrosis-treatment-taladegib-shows-significant-promise-in-landmark-phase-iib-trial
  • Medical Research and Clinical Trials

Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial

Neng Nana October 9, 2026
Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says navigating-the-intersection-of-glp-1-medications-and-breast-cancer-what-the-science-says
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says

Iffa Jayyana October 9, 2026
A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness a-global-beacon-of-hope-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness
  • Patient Advocacy and Support

A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

Layla Zulfa October 9, 2026
Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth groundbreaking-oklahoma-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth-1
  • Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Basiran October 9, 2026
NORMAN, OK – In a significant leap forward for cancer research, scientists at the University of Oklahoma...
Read More Read more about Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth
Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial breakthrough-in-idiopathic-pulmonary-fibrosis-treatment-taladegib-shows-significant-promise-in-landmark-phase-iib-trial
  • Medical Research and Clinical Trials

Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial

Neng Nana October 9, 2026
Endeavor BioMedicines announces pivotal Phase IIb WHISTLE-PF trial results, demonstrating taladegib’s potential to redefine IPF treatment by...
Read More Read more about Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial
Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says navigating-the-intersection-of-glp-1-medications-and-breast-cancer-what-the-science-says
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says

Iffa Jayyana October 9, 2026
By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) medications have surged in...
Read More Read more about Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says
A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness a-global-beacon-of-hope-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness
  • Patient Advocacy and Support

A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

Layla Zulfa October 9, 2026
NEW YORK, NY — As the world enters the mid-point of Breast Cancer Awareness Month, a global...
Read More Read more about A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness
Beyond the Ribbon: BCRF Transforms Grand Central Terminal into a Hub for Lifesaving Research beyond-the-ribbon-bcrf-transforms-grand-central-terminal-into-a-hub-for-lifesaving-research
  • Patient Advocacy and Support

Beyond the Ribbon: BCRF Transforms Grand Central Terminal into a Hub for Lifesaving Research

Suro Senen October 9, 2026
NEW YORK CITY – In a powerful demonstration of the intersection between public advocacy and scientific rigor,...
Read More Read more about Beyond the Ribbon: BCRF Transforms Grand Central Terminal into a Hub for Lifesaving Research
National Survey Signals Urgent Call for Unified Canadian Breast Cancer Strategy: Closing the Gaps from Screening to Survivorship national-survey-signals-urgent-call-for-unified-canadian-breast-cancer-strategy-closing-the-gaps-from-screening-to-survivorship
  • Patient Advocacy and Support

National Survey Signals Urgent Call for Unified Canadian Breast Cancer Strategy: Closing the Gaps from Screening to Survivorship

Iffa Jayyana October 9, 2026
OTTAWA – A landmark national survey released by Breast Cancer Canada has revealed a profound public demand...
Read More Read more about National Survey Signals Urgent Call for Unified Canadian Breast Cancer Strategy: Closing the Gaps from Screening to Survivorship
Strengthening Global Health: WHO Director-General Highlights Jordan’s Vital Role in Humanitarian Crisis strengthening-global-health-who-director-general-highlights-jordans-vital-role-in-humanitarian-crisis
  • Breast Cancer Prevention and Lifestyle

Strengthening Global Health: WHO Director-General Highlights Jordan’s Vital Role in Humanitarian Crisis

Asro October 9, 2026
AMMAN, Jordan — The World Health Organization (WHO) Director-General, Dr. Tedros Adhanom Ghebreyesus, has concluded the opening...
Read More Read more about Strengthening Global Health: WHO Director-General Highlights Jordan’s Vital Role in Humanitarian Crisis
The Biotech Crossroads: Navigating Market Volatility and the Private M&A Boom the-biotech-crossroads-navigating-market-volatility-and-the-private-ma-boom
  • Treatment Innovations

The Biotech Crossroads: Navigating Market Volatility and the Private M&A Boom

Nana Wu October 9, 2026
This is the latest installment in a new series where BioPharma Dive uses data visualization to recap...
Read More Read more about The Biotech Crossroads: Navigating Market Volatility and the Private M&A Boom
Unlocking Hidden Data: How AI is Revolutionizing MASLD Diagnosis and Patient Care unlocking-hidden-data-how-ai-is-revolutionizing-masld-diagnosis-and-patient-care
  • Treatment Innovations

Unlocking Hidden Data: How AI is Revolutionizing MASLD Diagnosis and Patient Care

Siti Muinah October 9, 2026
In the rapidly evolving landscape of medical technology, a significant breakthrough has emerged in the fight against...
Read More Read more about Unlocking Hidden Data: How AI is Revolutionizing MASLD Diagnosis and Patient Care
Beyond the Microscope: How Digital Pathology is Transforming Drug Discovery and Reducing Animal Reliance beyond-the-microscope-how-digital-pathology-is-transforming-drug-discovery-and-reducing-animal-reliance
  • Treatment Innovations

Beyond the Microscope: How Digital Pathology is Transforming Drug Discovery and Reducing Animal Reliance

Reynand Wu October 9, 2026
For decades, the standard workflow in preclinical toxicology remained stubbornly static: a pathologist would peer through a...
Read More Read more about Beyond the Microscope: How Digital Pathology is Transforming Drug Discovery and Reducing Animal Reliance

Posts pagination

1 2 3 4 … 716 Next

Recent Posts

  • Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth
  • Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial
  • Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says
  • A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness
  • Beyond the Ribbon: BCRF Transforms Grand Central Terminal into a Hub for Lifesaving Research

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

groundbreaking-oklahoma-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth-1
  • Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Basiran October 9, 2026
breakthrough-in-idiopathic-pulmonary-fibrosis-treatment-taladegib-shows-significant-promise-in-landmark-phase-iib-trial
  • Medical Research and Clinical Trials

Breakthrough in Idiopathic Pulmonary Fibrosis Treatment: Taladegib Shows Significant Promise in Landmark Phase IIb Trial

Neng Nana October 9, 2026
navigating-the-intersection-of-glp-1-medications-and-breast-cancer-what-the-science-says
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Science Says

Iffa Jayyana October 9, 2026
a-global-beacon-of-hope-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness
  • Patient Advocacy and Support

A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

Layla Zulfa October 9, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.